Clinical Trials in Tennessee

Showing 9101-9120 of 20,239 trials

Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans

NCT02537314

The overall hypothesis of this proposal is that nutrient sensing in the foregut regulates metabolic hormone secretion and nutrient metabolism via enteric neural signals, and these mechanisms might be defective in obesity.

Obesity

Vanderbilt University Medical Center27 participantsStarted Sep 2015

Nashville, Tennessee, United States

TERMINATEDPhase 129 miles

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

NCT04672980

This is an open-label, multicenter, multiple-ascending dose, FIH, Phase 1 study of RTX-321 for the treatment of patients that are HLA-A\*02:01 positive with persistent, recurrent, or metastatic, unresectable, HPV 16+ cancers.

Cervical CancerHead and Neck CancerAnal Cancer

Rubius Therapeutics9 participantsStarted Apr 2021

Birmingham, Alabama, United States • Los Angeles, California, United States • Aurora, Colorado, United States +7 more locations

COMPLETEDNA29 miles

Improving CarE for Community Acquired Pneumonia 1

NCT03760419

Children with pneumonia presenting to the emergency department at Monroe Carell Jr. Children's Hospital at Vanderbilt or Children's Hospital of Pittsburgh will be potentially eligible for study. During intervention periods, providers caring for enrolled children will be presented with a detailed decision support strategy that emphasizes management in accordance with national guideline recommendations. The anticipated study duration is 18 months and, as this study does not include direct contact with enrolled subjects, there is no anticipated follow up.

Pneumonia Childhood

Vanderbilt University Medical Center1,027 participantsStarted Dec 2018

Nashville, Tennessee, United States

Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

Improving CarE for Community Acquired Pneumonia 1

Find Trials by Condition in Tennessee

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Comparison Study of 3 Ostomy Products

Vitala 12 Hour Wear Test With Convex Products

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory